Clinical
Grounded in a decade of neuroscience and validated against major depressive disorder.
Soihtu DTx is building Meliora — the first personalized, precision digital therapeutic delivered as a video game for major depressive disorder.
Our approach
Grounded in a decade of neuroscience and validated against major depressive disorder.
An immersive narrative game patients actually want to return to, day after day.
Adaptive training that tunes difficulty and pacing to each person in real time.
Delivered as software — accessible anywhere, without waitlists or clinic hours.
Flagship product
A clinically-validated video game that treats major depressive disorder by pairing adaptive cognitive training with an immersive narrative.
Meliora targets the cognitive deficits and fronto-parietal hypoactivity that antidepressants and psychotherapy don't address. In early trials it produced significant symptom reduction — results comparable to psychotherapy, but faster.
How it works
Baseline cognitive and symptom profiling pinpoints each patient's deficits.
The game continuously recalibrates difficulty to keep training in the optimal zone.
Sustained, targeted engagement drives measurable reduction in depressive symptoms.
“A treatment that reaches the cognitive roots of depression — delivered through something people want to play.”
Validated through a large-scale clinical trial, with early results showing symptom reduction comparable to psychotherapy.
Backed by
Selected for Techstars '23 Accelerator
Soihtu DTx was selected into the 2023 Techstars Accelerator, joining a global program supporting the most promising early-stage health and technology companies.
Founders & team
A cross-disciplinary team that uniquely combines neuroscience, psychology and game development.
CEO & Co-Founder
Chief Psychology Officer & Co-Founder
CTO
Lead Game Designer
Whether you're a clinician, researcher, investor or journalist — explore the science behind Meliora or get in touch.
For clinical partnerships, investment, or press — we'd love to hear from you.
[email protected]